Live from the NIH registry
Studies recruiting near Dayton right now
Top 25 of 308 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Kettering Health — Kettering, Ohio (6.5 mi)
· Sponsor: American Society of Clinical Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Miami Valley Hospital South — Centerville, Ohio (10.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Hometown Urgent Care and Research - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Crystalys Therapeutics
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro — Springboro, Ohio (15.9 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Good Samaritan Hospital - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Arthritis and Rheumatology of Southwest Ohio — Liberty Township, Ohio (28.1 mi)
· Sponsor: University of Alabama at Birmingham
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 120 participants sought
The Children's Medical Center of Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Stat Research — Miamisburg, Ohio (10.6 mi)
· Sponsor: Amgen
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
304 — Centerville, Ohio (10.7 mi)
· Sponsor: Corcept Therapeutics
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
Photosensitivity, Microvesicle Particle
Phase 1
Interventional 40 participants sought
Wright State Physicians — Fairborn, Ohio (10.0 mi)
· Sponsor: Wright State University
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Nicole Hamblett
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Beavercreek, Ohio (8.8 mi)
· Sponsor: Xencor, Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Heart House Research Foundation LLC — Springfield, Ohio (23.0 mi)
· Sponsor: Duke University
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7081 — Dayton, Ohio (1.6 mi)
· Sponsor: Galderma R&D
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1122 — Dayton, Ohio (1.6 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Cincinnati Children's Hospital Medical Center Liberty — Liberty Township, Ohio (28.1 mi)
· Sponsor: Pfizer
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Springboro, Ohio (15.9 mi)
· Sponsor: Akero Therapeutics, Inc
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Premier Blood and Cancer Center — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Dayton Center for Neurological Disorders — Centerville, Ohio (10.7 mi)
· Sponsor: Pfizer